Nucleic acid polymers: much-needed hope for hepatitis D? (Q47568109)

4 February 2018

title

Nucleic acid polymers: much-needed hope for hepatitis D? (English)

1 reference

4 February 2018

author name string

Dulce Alfaiate

series ordinal

1

1 reference

4 February 2018

Francesco Negro

series ordinal

2

1 reference

4 February 2018

publication date

27 September 2017

1 reference

4 February 2018

The lancet. Gastroenterology & hepatology

published in

1 reference

4 February 2018

volume

2

1 reference

4 February 2018

page(s)

841-842

1 reference

4 February 2018

issue

12

1 reference

4 February 2018

Safety and efficacy of REP 2139 and pegylated interferon alfa-2a for treatment-naive patients with chronic hepatitis B virus and hepatitis D virus co-infection (REP 301 and REP 301-LTF): a non-randomised, open-label, phase 2 trial

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930292-3

7 January 2021

EASL 2017 Clinical Practice Guidelines on the management of hepatitis B virus infection

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930292-3

7 January 2021

Late HDV RNA relapse after peginterferon alpha-based therapy of chronic hepatitis delta

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930292-3

7 January 2021

Nucleic acid polymers: Broad spectrum antiviral activity, antiviral mechanisms and optimization for the treatment of hepatitis B and hepatitis D infection

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930292-3

7 January 2021

The hepatitis delta virus: Replication and pathogenesis

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930292-3

7 January 2021

Safety and Efficacy of Nucleic Acid Polymers in Monotherapy and Combined with Immunotherapy in Treatment-Naive Bangladeshi Patients with HBeAg+ Chronic Hepatitis B Infection

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930292-3

7 January 2021

Nucleic acid-based polymers effective against hepatitis B Virus infection in patients don't harbor immunostimulatory properties in primary isolated liver cells

1 reference

https://api.crossref.org/works/10.1016%2FS2468-1253%2817%2930292-3

7 January 2021

10.1016/S2468-1253(17)30292-3

Identifiers

DOI

1 reference

4 February 2018

PubMed ID

28964702

1 reference

4 February 2018